Methods and devices to induce controlled atelectasis and hypoxic pulmonary vasoconstriction
US8136526B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2007 |
| Grant date | Mar 20, 2012 |
| Priority date | — |
| Expiry date | Apr 28, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61F2002/068
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Lung conditions are treated by implanting a flow restrictor in a passageway upstream from a diseased lung segment. The restrictor will create an orifice at the implantation site which inhibits air exchange with the segment to induce controlled atelectasis and/or hypoxia. Controlled atelectasis can induce collapse of the diseased segment with a reduced risk of pneumothorax. Hypoxia can promote gas exchange with non-isolated, healthy regions of the lung even in the absence of lung collapse.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.